Cholera toxin-induced PGE2 activity is reduced by chemical reaction with L-histidine

Johnny Peterson, David King, Edward L. Ezell, Mark Rogers, Deborah Gessell, Jennifer Hoffpauer, Luis Reuss, Ashok Chopra, David Gorenstein

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mediators of cholera toxin (CT)-induced fluid secretion include 3′,5′-adenosine monophosphate (cAMP), prostaglandin E2 (PGE2), and 5-hydroxytryptamine (5-HT). Administration of L-histidine significantly reduced the net secretory response of the small intestine of mice challenged with CT and reduced the capacity of PGE2 to stimulate Na+ transport in Ussing chambers. We demonstrated that L-histidine chemically modified the structure of PGE2 but had no direct effect on cAMP or 5-HT. L-Histidine and imidazole reacted with PGE2 in vitro in cell-free mixtures incubated at 37°C and pH 7.0 under an atmosphere of N2 with the formation of PGE2-imidazole and PGE2-histidine covalent adducts. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) analysis of the purified adduct showed that imidazole catalyzed the dehydration of PGE2. A Michael adduct then was formed between C11 of 11-deoxy-Δ10 PGE2 (PGA2) and the tau nitrogen in the imidazole ring of L-histidine. Importantly, the isolated PGE2-imidazole and PGE2-histidine adducts inhibited CT-induced fluid loss and cAMP accumulation in mouse intestinal loops. The protection provided by PGE2-imidazole, PGE2-histidine, and L-histidine against intestinal fluid loss could provide a basis for future therapy against cholera.

Original languageEnglish (US)
Pages (from-to)27-41
Number of pages15
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1537
Issue number1
DOIs
StatePublished - Jul 27 2001

Fingerprint

Cholera Toxin
Dinoprostone
Histidine
Serotonin
Fluids and Secretions
Cholera
Adenosine Monophosphate
Atmosphere
Dehydration
Small Intestine
imidazole
Mass Spectrometry
Magnetic Resonance Spectroscopy
Nitrogen

Keywords

  • Cholera toxin
  • Imidazole
  • L-Histidine
  • Prostaglandin
  • Structure

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Biophysics

Cite this

Cholera toxin-induced PGE2 activity is reduced by chemical reaction with L-histidine. / Peterson, Johnny; King, David; Ezell, Edward L.; Rogers, Mark; Gessell, Deborah; Hoffpauer, Jennifer; Reuss, Luis; Chopra, Ashok; Gorenstein, David.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1537, No. 1, 27.07.2001, p. 27-41.

Research output: Contribution to journalArticle

Peterson, Johnny ; King, David ; Ezell, Edward L. ; Rogers, Mark ; Gessell, Deborah ; Hoffpauer, Jennifer ; Reuss, Luis ; Chopra, Ashok ; Gorenstein, David. / Cholera toxin-induced PGE2 activity is reduced by chemical reaction with L-histidine. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2001 ; Vol. 1537, No. 1. pp. 27-41.
@article{1245f166b79e44f8a9ece69a4054614b,
title = "Cholera toxin-induced PGE2 activity is reduced by chemical reaction with L-histidine",
abstract = "Mediators of cholera toxin (CT)-induced fluid secretion include 3′,5′-adenosine monophosphate (cAMP), prostaglandin E2 (PGE2), and 5-hydroxytryptamine (5-HT). Administration of L-histidine significantly reduced the net secretory response of the small intestine of mice challenged with CT and reduced the capacity of PGE2 to stimulate Na+ transport in Ussing chambers. We demonstrated that L-histidine chemically modified the structure of PGE2 but had no direct effect on cAMP or 5-HT. L-Histidine and imidazole reacted with PGE2 in vitro in cell-free mixtures incubated at 37°C and pH 7.0 under an atmosphere of N2 with the formation of PGE2-imidazole and PGE2-histidine covalent adducts. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) analysis of the purified adduct showed that imidazole catalyzed the dehydration of PGE2. A Michael adduct then was formed between C11 of 11-deoxy-Δ10 PGE2 (PGA2) and the tau nitrogen in the imidazole ring of L-histidine. Importantly, the isolated PGE2-imidazole and PGE2-histidine adducts inhibited CT-induced fluid loss and cAMP accumulation in mouse intestinal loops. The protection provided by PGE2-imidazole, PGE2-histidine, and L-histidine against intestinal fluid loss could provide a basis for future therapy against cholera.",
keywords = "Cholera toxin, Imidazole, L-Histidine, Prostaglandin, Structure",
author = "Johnny Peterson and David King and Ezell, {Edward L.} and Mark Rogers and Deborah Gessell and Jennifer Hoffpauer and Luis Reuss and Ashok Chopra and David Gorenstein",
year = "2001",
month = "7",
day = "27",
doi = "10.1016/S0925-4439(01)00052-7",
language = "English (US)",
volume = "1537",
pages = "27--41",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Cholera toxin-induced PGE2 activity is reduced by chemical reaction with L-histidine

AU - Peterson, Johnny

AU - King, David

AU - Ezell, Edward L.

AU - Rogers, Mark

AU - Gessell, Deborah

AU - Hoffpauer, Jennifer

AU - Reuss, Luis

AU - Chopra, Ashok

AU - Gorenstein, David

PY - 2001/7/27

Y1 - 2001/7/27

N2 - Mediators of cholera toxin (CT)-induced fluid secretion include 3′,5′-adenosine monophosphate (cAMP), prostaglandin E2 (PGE2), and 5-hydroxytryptamine (5-HT). Administration of L-histidine significantly reduced the net secretory response of the small intestine of mice challenged with CT and reduced the capacity of PGE2 to stimulate Na+ transport in Ussing chambers. We demonstrated that L-histidine chemically modified the structure of PGE2 but had no direct effect on cAMP or 5-HT. L-Histidine and imidazole reacted with PGE2 in vitro in cell-free mixtures incubated at 37°C and pH 7.0 under an atmosphere of N2 with the formation of PGE2-imidazole and PGE2-histidine covalent adducts. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) analysis of the purified adduct showed that imidazole catalyzed the dehydration of PGE2. A Michael adduct then was formed between C11 of 11-deoxy-Δ10 PGE2 (PGA2) and the tau nitrogen in the imidazole ring of L-histidine. Importantly, the isolated PGE2-imidazole and PGE2-histidine adducts inhibited CT-induced fluid loss and cAMP accumulation in mouse intestinal loops. The protection provided by PGE2-imidazole, PGE2-histidine, and L-histidine against intestinal fluid loss could provide a basis for future therapy against cholera.

AB - Mediators of cholera toxin (CT)-induced fluid secretion include 3′,5′-adenosine monophosphate (cAMP), prostaglandin E2 (PGE2), and 5-hydroxytryptamine (5-HT). Administration of L-histidine significantly reduced the net secretory response of the small intestine of mice challenged with CT and reduced the capacity of PGE2 to stimulate Na+ transport in Ussing chambers. We demonstrated that L-histidine chemically modified the structure of PGE2 but had no direct effect on cAMP or 5-HT. L-Histidine and imidazole reacted with PGE2 in vitro in cell-free mixtures incubated at 37°C and pH 7.0 under an atmosphere of N2 with the formation of PGE2-imidazole and PGE2-histidine covalent adducts. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) analysis of the purified adduct showed that imidazole catalyzed the dehydration of PGE2. A Michael adduct then was formed between C11 of 11-deoxy-Δ10 PGE2 (PGA2) and the tau nitrogen in the imidazole ring of L-histidine. Importantly, the isolated PGE2-imidazole and PGE2-histidine adducts inhibited CT-induced fluid loss and cAMP accumulation in mouse intestinal loops. The protection provided by PGE2-imidazole, PGE2-histidine, and L-histidine against intestinal fluid loss could provide a basis for future therapy against cholera.

KW - Cholera toxin

KW - Imidazole

KW - L-Histidine

KW - Prostaglandin

KW - Structure

UR - http://www.scopus.com/inward/record.url?scp=0035958702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035958702&partnerID=8YFLogxK

U2 - 10.1016/S0925-4439(01)00052-7

DO - 10.1016/S0925-4439(01)00052-7

M3 - Article

VL - 1537

SP - 27

EP - 41

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1

ER -